Overview

Investigate Two Trial Models; Vienna Challenge Chamber (in and Out of Season) and Park Study (in Season) Using a Drug for Seasonal Allergic Rhinitis

Status:
Completed

Trial end date:
2006-11-01

Target enrollment:

Participant gender:

Summary

The aim of the study is to investigate the trial models, Vienna Challenge Chamber (VCC), in and out of season, and Park Study in season and the clinical efficacy of repeat doses of fluticasone propionate in subjects with seasonal allergic rhinitis.

Phase:

Phase 2

Details

Lead Sponsor:

GlaxoSmithKline
Research Consult GmbH

Treatments:

Fluticasone
Polystyrene sulfonic acid
Xhance